Oct 21 (Reuters) - Sweden's EQT will buy molecular testing company Qiagen for about €9.6 billion ($10.78 billion), the ...

Scientists at NPL, with the University of Surrey, University of Oxford, the Francis Crick Institute and IONTOF GmbH, have ...

MIT researchers created a nanosensor catheter that detects bladder cancer biomarkers far earlier than current tests.

Materials that change their shape upon exposure to light are attracting growing interest in applications such as soft ...

A Great Dane is lucky to see its 10th birthday, while a Chihuahua might live to celebrate its 20th. But exactly why smaller ...

Valuable new insights into how plants perceive their environment and protect themselves from biological threats in soil. The post Plants use molecular ‘measuring tape’ to tell friend from foe appeared ...

Attractive biodistribution supports selection of MP0730 as Radio-DARPin therapy candidate CD70 is a clinically validated target expressed in kidney cancer and other indicationsFirst-in-human program ...

AmplexDiagnostics and Scope Biosciences are proud to introduce a groundbreaking solution in molecular diagnostics. In a new ...

University of Bonn scientists reset 80-year-old blood cells to a molecular age under 20 in an Aging Cell study, reigniting ...

Add one double bond to a structural formula. That double bond connects with another double bond to become conjugated.Even if it looks like a small change, the light that the molecule absorbs may ...

In nematodes, a metabolite induced by the cold links low temperatures to a body-wide signal that promotes longevity. This signalling system is also seen in human cells.

EQT AB is nearing a deal to acquire Qiagen NV for around €9.6 billion ($10.8 billion) bringing an end to years of takeover speculation involving the European molecular testing company, according to ...